Literature DB >> 29241800

Vitiligo-like lesions in patients receiving anti-programmed cell death-1 therapies are distinct from spontaneously occurring active vitiligo.

Katia Boniface1, Caroline Dutriaux2, Sorilla Prey2, Alain Taieb2, Julien Seneschal3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29241800     DOI： 10.1016/j.jaad.2017.08.028

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study.

Authors:  Samy Babai; Anne-Laure Voisin; Célia Bertin; Amandine Gouverneur; Hervé Le-Louet
Journal:  Drug Saf       Date:  2020-02       Impact factor: 5.606

2.  Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.

Authors:  Pietro Sollena; Vasiliki Nikolaou; Nikolaos Soupos; Elias Kotteas; Dimitra Voudouri; Alexandros J Stratigos; Davide Fattore; Maria Carmela Annunziata; Armando Orlandi; Lucia Di Nardo; Zoe Apalla; Florian Deilhes; Maria Concetta Romano; Gabriella Fabbrocini; Vincent Sibaud; Ketty Peris
Journal:  Breast Cancer Res Treat       Date:  2020-09-10       Impact factor: 4.872

3.  Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer.

Authors:  David G Coffey; Yuexin Xu; Andrea M H Towlerton; Marcin Kowanetz; Priti Hegde; Martine Darwish; Mahesh Yadav; Craig Blanchette; Shannon M Ruppert; Sarah Bertino; Qikai Xu; Andrew Ferretti; Adam Weinheimer; Matthew Hellmann; Angel Qin; Dafydd Thomas; Edus H Warren; Nithya Ramnath
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

4.  Vitiligo in a patient undergoing nivolumab treatment for non-small cell lung cancer.

Authors:  Cory Kosche; Nisha Mohindra; Jennifer N Choi
Journal:  JAAD Case Rep       Date:  2018-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.